Crossref journal-article
Wiley
Angewandte Chemie International Edition (311)
Abstract

AbstractStructure‐based design usually focuses upon the optimization of ligand affinity. However, successful drug design also requires the optimization of many other properties. The primary source of structural information for protein–ligand complexes is X‐ray crystallography. The uncertainties introduced during the derivation of an atomic model from the experimentally observed electron density data are not always appreciated. Uncertainties in the atomic model can have significant consequences when this model is subsequently used as the basis of manual design, docking, scoring, and virtual screening efforts. Docking and scoring algorithms are currently imperfect. A good correlation between observed and calculated binding affinities is usually only observed only when very large ranges of affinity are considered. Errors in the correlation often exceed the range of affinities commonly encountered during lead optimization. Some structure‐based design approaches now involve screening libraries by using technologies based on NMR spectroscopy and X‐ray crystallography to discover small polar templates, which are used for further optimization. Such compounds are defined as leadlike and are also sought by more traditional high‐throughput screening technologies. Structure‐based design and HTS technologies show important complementarity and a degree of convergence.

Bibliography

Davis, A. M., Teague, S. J., & Kleywegt, G. J. (2003). Application and Limitations of X‐ray Crystallographic Data in Structure‐Based Ligand and Drug Design. Angewandte Chemie International Edition, 42(24), 2718–2736. Portico.

Authors 3
  1. Andrew M. Davis (first)
  2. Simon J. Teague (additional)
  3. Gerard J. Kleywegt (additional)
References 137 Referenced 315
  1. 10.1107/S0108767390010224
  2. 10.1107/S0907444998003254
  3. {'key': 'e_1_2_9_3_2', 'volume-title': 'X‐PLOR. A System for Crystallography and NMR”', 'author': 'Brünger A. T.', 'year': '1990'} / X‐PLOR. A System for Crystallography and NMR” by Brünger A. T. (1990)
  4. 10.1107/S0907444994003112 / Acta Crystallogr. Sect. D by 4 Collaborative Computational Project Number (1994)
  5. 10.1146/annurev.biophys.29.1.291
  6. 10.1007/BF00124402
  7. 10.1006/jmbi.1996.0477
  8. 10.1006/jmbi.1996.0897
  9. 10.1021/jm00145a002
  10. 10.1002/prot.340110104
  11. 10.1107/S0907444998007124
  12. 10.1006/jmbi.1999.2809
  13. 10.1007/BF00126743 / J. Comput. ‐Aided. Mol. Des. by Bohm H. J. (1994)
  14. 10.1006/jmbi.1999.3371
  15. 10.1021/jm0105833
  16. 10.1007/BF02174464
  17. 10.1021/ja00226a005
  18. 10.1002/qsar.19930120103
  19. LEAPFROG Tripos Inc. 1699 South Hanley Rd. St Louis MO 63144 USA.
  20. 10.1021/ar970146b
  21. 10.1021/ci00017a027
  22. UNITY 4.2.1 Tripos Inc. 1699 South Hanley Rd. St Louis MO 63144 USA.
  23. 10.1002/(SICI)1097-0134(19981001)33:1<74::AID-PROT7>3.0.CO;2-L
  24. 10.1126/science.274.5292.1531
  25. 10.1016/S1074-5521(00)80022-8
  26. 10.1038/80319
  27. 10.1038/nrd706
  28. 10.1038/314235a0
  29. 10.1073/pnas.90.4.1172
  30. 10.1023/A:1008708418253
  31. 10.1016/S0169-409X(96)00423-1
  32. 10.1021/jm970666c
  33. http://setiathome.ssl.berkeley.edu/.
  34. http://www.chem.ox.ac.uk/curecancer.html.
  35. 10.1007/978-3-662-04383-7_1
  36. 10.1016/S0065-7743(08)60591-6
  37. 10.1016/S1359-6446(01)02091-8
  38. 10.1021/cr960370z
  39. {'key': 'e_1_2_9_39_2', 'first-page': '137', 'volume-title': 'Methods and Principles in Medicinal Chemistry Volume 14 Bioinformatics—From Genome to Drug', 'author': 'Stahl M.', 'year': '2002'} / Methods and Principles in Medicinal Chemistry Volume 14 Bioinformatics—From Genome to Drug by Stahl M. (2002)
  40. 10.1021/jm010425b
  41. 10.1124/mol.59.4.806
  42. 10.1016/S0169-409X(99)00027-7
  43. 10.1358/dof.1998.023.09.473829
  44. 10.1016/S1074-5521(98)90117-X
  45. 10.1358/dof.1998.023.09.858365
  46. 10.1038/363418a0
  47. Physicians' Desk Reference 55. edition Thomson Medical Economics Montvale 2001 p. 1454.
  48. 10.1021/ja963036t
  49. R&D Insight 2000 ADIS International Ltd. Chester United Kingdom.
  50. 10.1016/S0021-9258(18)90804-5 / J. Biol. Chem. by Navia M. A. (1984)
  51. 10.1126/science.2493678
  52. 10.1016/1359-6446(96)10020-9
  53. 10.1016/S1074-5521(99)89004-8
  54. 10.3109/10799899909036635
  55. 10.1021/jm00034a001
  56. 10.1007/0-306-47384-4_24
  57. 10.1038/nsb0695-458
  58. 10.1016/S1388-1981(99)00157-2
  59. 10.1007/978-1-4757-2335-9
  60. 10.1016/S0076-6879(97)77012-5
  61. 10.1016/S0076-6879(97)77013-7
  62. 10.1016/S0022-2836(77)80200-3
  63. http://www.rcsb.org/pdb.
  64. 10.1107/S0907444999016364
  65. {'key': 'e_1_2_9_66_2', 'first-page': '11', 'volume-title': 'Making the Most of Your Model', 'author': 'Kleywegt G. J.', 'year': '1995'} / Making the Most of Your Model by Kleywegt G. J. (1995)
  66. 10.1038/343687a0
  67. 10.1021/ja005533m
  68. 10.1021/ja025109g
  69. 10.1038/355472a0
  70. 10.1016/S0969-2126(01)00187-3
  71. 10.1016/S0076-6879(97)77021-6
  72. 10.1016/S0969-2126(96)00097-4
  73. 10.1038/381272a0
  74. http://www.cmbi.kun.nl/gv/pdbreport.
  75. J. Y. Zou M. R. Harris T. Taylor A. Wählby G. J. Kleywegt T. A. Jones unpublished results.
  76. 10.1126/science.3775366
  77. 10.1126/science.1069556
  78. 10.1016/S0969-2126(94)00125-1
  79. {'key': 'e_1_2_9_80_2', 'first-page': '155', 'volume-title': 'Enzyme Structure and Mechanism', 'author': 'Fersht A.', 'year': '1985'} / Enzyme Structure and Mechanism by Fersht A. (1985)
  80. 10.1007/978-1-4615-4141-7_11
  81. 10.1002/1439-7633(20020301)3:2/3<246::AID-CBIC246>3.0.CO;2-#
  82. 10.1016/S0969-2126(01)00261-1
  83. 10.1002/pro.5560050408
  84. 10.1042/bj3460201
  85. 10.1006/jmbi.1998.1931
  86. 10.1016/S0969-2126(97)00222-0
  87. 10.1093/protein/9.12.1083
  88. “Options for the Control of Influenza IV”: A. Harris F. Forouhar S. Qiu S. Shihong L. M. Bingdong Int. Congress Series 2001 1219 405–410. (10.1016/S0531-5131(01)00349-1)
  89. 10.1107/S0907444901021758
  90. 10.1107/S090744499300808X
  91. 10.1107/S0907444994002659
  92. 10.1107/S0907444994003021
  93. 10.1016/S1074-5521(96)90164-7
  94. 10.1023/A:1015930826903
  95. 10.1107/S0907444998007100
  96. http:// xray.bmc.uu.se/hicup.
  97. 10.1007/BF00355047
  98. 10.1016/S0021-9258(19)74325-7 / J. Biol. Chem. by Eads J. (1993)
  99. 10.1074/jbc.272.11.7140
  100. 10.1021/bi00054a019
  101. 10.1002/prot.10232
  102. 10.1002/1521-1878(200011)22:11<1024::AID-BIES9>3.0.CO;2-W
  103. http://www.expasy.ch/spdbv.
  104. 10.1016/S0969-2126(02)00743-8
  105. http://fsrv1.bmc.uu.se/eds.
  106. http://xray.bmc.uu.se/embo2001/modval.
  107. 10.1021/bi00057a028
  108. 10.1021/bi0107400
  109. 10.1002/pro.5560071002
  110. http://www.ccdc.cam.ac.uk/prods/gold/value.html.
  111. 10.1023/A:1008015827877
  112. 10.1021/ar00028a003
  113. 10.1021/cr9400976
  114. 10.1039/a827057z
  115. 10.1021/bi00368a028
  116. 10.1021/jm980536j
  117. {'key': 'e_1_2_9_118_2', 'first-page': '445', 'volume': '9', 'author': 'Bohm H.‐J.', 'year': '1999', 'journal-title': 'Med. Chem. Res.'} / Med. Chem. Res. by Bohm H.‐J. (1999)
  118. 10.1021/ja9539002
  119. 10.1023/A:1027299602978
  120. 10.1021/jm00002a012
  121. 10.1002/(SICI)1521-3757(19990315)111:6<778::AID-ANGE778>3.0.CO;2-C
  122. 10.1002/(SICI)1521-3773(19990315)38:6<736::AID-ANIE736>3.0.CO;2-R
  123. 10.1002/(SICI)1097-0134(20000515)39:3<261::AID-PROT90>3.0.CO;2-4
  124. {'key': 'e_1_2_9_124_2', 'first-page': '215', 'volume': '42', 'author': 'Goodford P.', 'year': '1998', 'journal-title': 'Alfred Benzon Symp.'} / Alfred Benzon Symp. by Goodford P. (1998)
  125. 10.1023/A:1008737207775
  126. 10.1016/S1074-5521(01)00023-0
  127. 10.1021/ja003972f
  128. 10.1021/ja960897t
  129. 10.1002/(SICI)1521-3757(19991216)111:24<3962::AID-ANGE3962>3.0.CO;2-8
  130. 10.1002/(SICI)1521-3773(19991216)38:24<3743::AID-ANIE3743>3.0.CO;2-U
  131. 10.1021/ci010366a
  132. 10.1021/ci000403i
  133. 10.1016/S0969-2126(98)00086-0
  134. 10.1021/jm010548w
  135. 10.1021/jm010944e
  136. 10.1016/S1074-5521(97)90073-9
Dates
Type When
Created 22 years, 2 months ago (June 18, 2003, 6:13 a.m.)
Deposited 1 year, 10 months ago (Oct. 11, 2023, 5:10 p.m.)
Indexed 3 weeks, 5 days ago (July 30, 2025, 10:45 a.m.)
Issued 22 years, 2 months ago (June 17, 2003)
Published 22 years, 2 months ago (June 17, 2003)
Published Online 22 years, 2 months ago (June 17, 2003)
Published Print 22 years, 2 months ago (June 23, 2003)
Funders 0

None

@article{Davis_2003, title={Application and Limitations of X‐ray Crystallographic Data in Structure‐Based Ligand and Drug Design}, volume={42}, ISSN={1521-3773}, url={http://dx.doi.org/10.1002/anie.200200539}, DOI={10.1002/anie.200200539}, number={24}, journal={Angewandte Chemie International Edition}, publisher={Wiley}, author={Davis, Andrew M. and Teague, Simon J. and Kleywegt, Gerard J.}, year={2003}, month=jun, pages={2718–2736} }